LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.840
-0.050 (-2.65%)
Nov 7, 2024, 4:00 PM EST - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $48.39 million as of November 7, 2024. Its market cap has increased by 29.62% in one year.
Market Cap
48.39M
Enterprise Value
-32.25M
1-Year Change
29.62%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $48.39M, a decrease of -87.28%. That is a compound annual growth rate of -43.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2024 | 49.96M | 20.29% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aadi Bioscience | 50.71M |
| Cytosorbents | 50.65M |
| SCYNEXIS | 49.97M |
| iCAD, Inc. | 49.95M |
| Rapid Micro Biosystems | 49.35M |
| Allurion Technologies | 48.98M |
| Serina Therapeutics | 48.62M |
| Anebulo Pharmaceuticals | 48.50M |